DSG2 and neoplasm: Furthermore, A431-Dsg2/GFP xenografts in immunocompromised mice resulted in significantly greater tumor growth and higher plasma sEV levels, and a single dose of 20 μg Dsg2 modulated sEVs was able to enhance the tumorigenic potential of A431-GFP xenografts.